Rapt Therapeutics Inc
NASDAQ:RAPT
Rapt Therapeutics Inc
NASDAQ:RAPT
Price:
58.005
USD
Market Cap:
$1.6B
Balance Sheet
Balance Sheet Decomposition
Rapt Therapeutics Inc
Rapt Therapeutics Inc
Balance Sheet Decomposition is not available for
Rapt Therapeutics Inc
Rapt Therapeutics Inc
Balance Sheet
Rapt Therapeutics Inc
Rapt Therapeutics Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
48
|
64
|
77
|
25
|
24
|
39
|
47
|
170
|
|
| Cash Equivalents |
48
|
64
|
77
|
25
|
24
|
39
|
47
|
170
|
|
| Short-Term Investments |
0
|
0
|
0
|
87
|
166
|
210
|
111
|
61
|
|
| Other Current Assets |
1
|
1
|
3
|
4
|
3
|
4
|
3
|
4
|
|
| Total Current Assets |
48
|
65
|
81
|
116
|
193
|
253
|
162
|
235
|
|
| PP&E Net |
2
|
4
|
4
|
3
|
3
|
10
|
8
|
5
|
|
| PP&E Gross |
2
|
4
|
4
|
3
|
3
|
10
|
8
|
5
|
|
| Accumulated Depreciation |
4
|
5
|
6
|
7
|
8
|
8
|
9
|
10
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
3
|
4
|
4
|
0
|
|
| Total Assets |
50
N/A
|
70
+38%
|
85
+22%
|
119
+41%
|
199
+67%
|
266
+34%
|
173
-35%
|
240
+39%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
2
|
1
|
2
|
2
|
3
|
5
|
1
|
|
| Accrued Liabilities |
2
|
3
|
4
|
5
|
6
|
11
|
17
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
5
|
4
|
1
|
0
|
0
|
35
|
|
| Total Current Liabilities |
3
|
5
|
9
|
12
|
10
|
14
|
22
|
48
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
2
|
3
|
3
|
7
|
4
|
2
|
|
| Total Liabilities |
4
N/A
|
6
+33%
|
12
+105%
|
15
+29%
|
12
-17%
|
21
+71%
|
26
+25%
|
50
+92%
|
|
| Equity | |||||||||
| Common Stock |
109
|
161
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
83
|
119
|
162
|
215
|
284
|
368
|
485
|
615
|
|
| Additional Paid In Capital |
21
|
22
|
235
|
319
|
471
|
613
|
632
|
804
|
|
| Other Equity |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
46
N/A
|
64
+39%
|
73
+14%
|
104
+43%
|
186
+79%
|
245
+32%
|
147
-40%
|
190
+29%
|
|
| Total Liabilities & Equity |
50
N/A
|
70
+38%
|
85
+22%
|
119
+41%
|
199
+67%
|
266
+34%
|
173
-35%
|
240
+39%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
3
|
4
|
4
|
4
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
